These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 5351517

  • 21. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY, Chinese Nephropathy Membranous Study Group.
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [Abstract] [Full Text] [Related]

  • 23. [Clinicopathological study of nephrotic syndrome in children, with special reference to the effects of adrenal cortex].
    Honda K.
    Nihon Shonika Gakkai Zasshi; 1971 Mar; 75(9):844-57. PubMed ID: 5165880
    [No Abstract] [Full Text] [Related]

  • 24. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K, Iskandar SS, Daeihagh P, Ratliff HL, Bleyer AJ.
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [Abstract] [Full Text] [Related]

  • 25. Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes.
    Jao W, Pollak VE, Norris SH, Lewy P, Pirani CL.
    Medicine (Baltimore); 1973 Sep; 52(5):445-68. PubMed ID: 4725964
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN, Lai FM, Ho CP, Chan KW.
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS, Turner DR, Ogg CS, Sharpstone P, Brown CB.
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract] [Full Text] [Related]

  • 38. Therapy of the idiopathic nephrotic syndrome with alternate day steroids.
    Bolton WK, Atuk NO, Sturgill BC, Westervelt FB.
    Am J Med; 1977 Jan; 62(1):60-70. PubMed ID: 835592
    [Abstract] [Full Text] [Related]

  • 39. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR, Feest TG, Morley AR, Tomlinson BE, Kerr DN.
    Lancet; 1972 Jun 10; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.